Insurance - Diversified
Compare Stocks
5 / 10Stock Comparison
GSHD vs SLQT vs HIFS vs RYAN vs ACGL
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Banks - Regional
Insurance - Specialty
Insurance - Diversified
GSHD vs SLQT vs HIFS vs RYAN vs ACGL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Diversified | Insurance - Brokers | Banks - Regional | Insurance - Specialty | Insurance - Diversified |
| Market Cap | $997M | $201M | $626M | $4.11B | $33.67B |
| Revenue (TTM) | $383M | $1.64B | $217M | $3.16B | $19.93B |
| Net Income (TTM) | $30M | $73M | $45M | $132M | $4.40B |
| Gross Margin | 73.7% | 69.8% | 30.1% | 69.4% | 37.2% |
| Operating Margin | 20.2% | 3.5% | 16.8% | 16.6% | 25.0% |
| Forward P/E | 19.4x | 85.7x | 20.4x | 14.9x | 10.1x |
| Total Debt | $352M | $416M | $1.50B | $3.53B | $2.73B |
| Cash & Equiv. | $34M | $32M | $352M | $158M | $993M |
GSHD vs SLQT vs HIFS vs RYAN vs ACGL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Goosehead Insurance… (GSHD) | 100 | 35.0 | -65.0% |
| SelectQuote, Inc. (SLQT) | 100 | 6.4 | -93.6% |
| Hingham Institution… (HIFS) | 100 | 96.0 | -4.0% |
| Ryan Specialty Hold… (RYAN) | 100 | 107.5 | +7.5% |
| Arch Capital Group … (ACGL) | 100 | 242.4 | +142.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GSHD vs SLQT vs HIFS vs RYAN vs ACGL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GSHD is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.64, yield 9.1%
- Beta 0.64, yield 9.1%, current ratio 7.60x
- 9.1% yield, 1-year raise streak, vs HIFS's 0.9%, (1 stock pays no dividend)
- 7.4% ROA vs HIFS's 1.0%, ROIC 38.6% vs 1.4%
SLQT is the clearest fit if your priority is growth exposure.
- Rev growth 15.5%, EPS growth 106.7%, 3Y rev CAGR 26.0%
HIFS ranks third and is worth considering specifically for momentum.
- +14.4% vs GSHD's -58.8%
RYAN is the clearest fit if your priority is growth.
- 21.3% revenue growth vs HIFS's 14.1%
ACGL carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 324.0% 10Y total return vs GSHD's 225.2%
- Lower volatility, beta 0.02, Low D/E 11.3%, current ratio 1.21x
- PEG 0.35 vs GSHD's 1.27
- Lower P/E (10.1x vs 14.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.3% revenue growth vs HIFS's 14.1% | |
| Value | Lower P/E (10.1x vs 14.9x) | |
| Quality / Margins | 22.1% margin vs RYAN's 4.2% | |
| Stability / Safety | Beta 0.02 vs SLQT's 1.96, lower leverage | |
| Dividends | 9.1% yield, 1-year raise streak, vs HIFS's 0.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +14.4% vs GSHD's -58.8% | |
| Efficiency (ROA) | 7.4% ROA vs HIFS's 1.0%, ROIC 38.6% vs 1.4% |
GSHD vs SLQT vs HIFS vs RYAN vs ACGL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GSHD vs SLQT vs HIFS vs RYAN vs ACGL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACGL leads in 3 of 6 categories
GSHD leads 2 • HIFS leads 1 • SLQT leads 0 • RYAN leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ACGL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACGL is the larger business by revenue, generating $19.9B annually — 91.7x HIFS's $217M. ACGL is the more profitable business, keeping 22.1% of every revenue dollar as net income compared to RYAN's 4.2%. On growth, GSHD holds the edge at +23.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $383M | $1.6B | $217M | $3.2B | $19.9B |
| EBITDAEarnings before interest/tax | $90M | $63M | $62M | $743M | $5.2B |
| Net IncomeAfter-tax profit | $30M | $73M | $45M | $132M | $4.4B |
| Free Cash FlowCash after capex | $95M | -$62M | $30M | $555M | $6.1B |
| Gross MarginGross profit ÷ Revenue | +73.7% | +69.8% | +30.1% | +69.4% | +37.2% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +3.5% | +16.8% | +16.6% | +25.0% |
| Net MarginNet income ÷ Revenue | +7.9% | +4.5% | +13.0% | +4.2% | +22.1% |
| FCF MarginFCF ÷ Revenue | +24.9% | -3.8% | +5.4% | +17.6% | +30.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.1% | +5.6% | — | +15.2% | +7.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.1% | -114.5% | +195.1% | +2.4% | +39.0% |
Valuation Metrics
ACGL leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.1x trailing earnings, ACGL trades at a 91% valuation discount to SLQT's 85.7x P/E. Adjusting for growth (PEG ratio), ACGL offers better value at 0.29x vs GSHD's 2.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $997M | $201M | $626M | $4.1B | $33.7B |
| Enterprise ValueMkt cap + debt − cash | $1.3B | $584M | $1.8B | $7.5B | $35.4B |
| Trailing P/EPrice ÷ TTM EPS | 40.50x | 85.71x | 22.33x | 67.49x | 8.13x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.42x | — | 20.43x | 14.90x | 10.05x |
| PEG RatioP/E ÷ EPS growth rate | 2.64x | — | — | — | 0.29x |
| EV / EBITDAEnterprise value multiple | 15.34x | 6.57x | 47.53x | 8.20x | 6.85x |
| Price / SalesMarket cap ÷ Revenue | 2.73x | 0.13x | 2.88x | 1.35x | 1.69x |
| Price / BookPrice ÷ Book value/share | — | 0.36x | 1.46x | 7.04x | 1.47x |
| Price / FCFMarket cap ÷ FCF | 11.58x | — | 53.27x | 7.14x | 5.50x |
Profitability & Efficiency
GSHD leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ACGL delivers a 19.0% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $10 for HIFS. ACGL carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIFS's 3.47x. On the Piotroski fundamental quality scale (0–9), GSHD scores 7/9 vs SLQT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +12.2% | +9.8% | +10.8% | +19.0% |
| ROA (TTM)Return on assets | +7.4% | +5.7% | +1.0% | +1.3% | +5.9% |
| ROICReturn on invested capital | +38.6% | +5.3% | +1.4% | +10.8% | +15.4% |
| ROCEReturn on capital employed | +19.0% | +6.7% | +2.2% | +6.4% | +11.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | — | 0.72x | 3.47x | 2.82x | 0.11x |
| Net DebtTotal debt minus cash | $318M | $384M | $1.1B | $3.4B | $1.7B |
| Cash & Equiv.Liquid assets | $34M | $32M | $352M | $158M | $993M |
| Total DebtShort + long-term debt | $352M | $416M | $1.5B | $3.5B | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | 3.55x | 4.11x | 0.44x | 2.29x | 34.86x |
Total Returns (Dividends Reinvested)
HIFS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACGL five years ago would be worth $24,398 today (with dividends reinvested), compared to $387 for SLQT. Over the past 12 months, HIFS leads with a +14.4% total return vs GSHD's -58.8%. The 3-year compound annual growth rate (CAGR) favors HIFS at 17.4% vs RYAN's -8.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -40.0% | -16.8% | +6.3% | -37.1% | +0.7% |
| 1-Year ReturnPast 12 months | -58.8% | -57.6% | +14.4% | -54.6% | +2.0% |
| 3-Year ReturnCumulative with dividends | -19.3% | -19.7% | +61.9% | -23.8% | +30.7% |
| 5-Year ReturnCumulative with dividends | -52.6% | -96.1% | -1.9% | +20.0% | +144.0% |
| 10-Year ReturnCumulative with dividends | +225.2% | -95.8% | +142.5% | +20.0% | +324.0% |
| CAGR (3Y)Annualised 3-year return | -6.9% | -7.1% | +17.4% | -8.6% | +9.3% |
Risk & Volatility
ACGL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ACGL is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than SLQT's 1.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACGL currently trades 91.4% from its 52-week high vs GSHD's 36.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 1.96x | 1.25x | 0.23x | 0.02x |
| 52-Week HighHighest price in past year | $114.76 | $2.80 | $338.00 | $72.50 | $103.39 |
| 52-Week LowLowest price in past year | $39.64 | $0.56 | $220.76 | $29.28 | $82.45 |
| % of 52W HighCurrent price vs 52-week peak | +36.7% | +40.7% | +84.9% | +43.8% | +91.4% |
| RSI (14)Momentum oscillator 0–100 | 39.3 | 71.7 | 51.0 | 28.8 | 46.3 |
| Avg Volume (50D)Average daily shares traded | 419K | 1.2M | 51K | 2.1M | 1.9M |
Analyst Outlook
GSHD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GSHD as "Buy", SLQT as "Hold", RYAN as "Buy", ACGL as "Buy". Consensus price targets imply 250.9% upside for SLQT (target: $4) vs 10.0% for ACGL (target: $104). For income investors, GSHD offers the higher dividend yield at 9.08% vs RYAN's 0.71%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | — | Buy | Buy |
| Price TargetConsensus 12-month target | $67.14 | $4.00 | — | $45.60 | $104.00 |
| # AnalystsCovering analysts | 18 | 11 | — | 19 | 34 |
| Dividend YieldAnnual dividend ÷ price | +9.1% | — | +0.9% | +0.7% | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $3.83 | — | $2.50 | $0.22 | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.2% | 0.0% | 0.0% | +0.1% | +5.6% |
ACGL leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). GSHD leads in 2 (Profitability & Efficiency, Analyst Outlook).
GSHD vs SLQT vs HIFS vs RYAN vs ACGL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GSHD or SLQT or HIFS or RYAN or ACGL a better buy right now?
For growth investors, Ryan Specialty Holdings, Inc.
(RYAN) is the stronger pick with 21. 3% revenue growth year-over-year, versus 14. 1% for Hingham Institution for Savings (HIFS). Arch Capital Group Ltd. (ACGL) offers the better valuation at 8. 1x trailing P/E (10. 1x forward), making it the more compelling value choice. Analysts rate Goosehead Insurance, Inc (GSHD) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GSHD or SLQT or HIFS or RYAN or ACGL?
On trailing P/E, Arch Capital Group Ltd.
(ACGL) is the cheapest at 8. 1x versus SelectQuote, Inc. at 85. 7x. On forward P/E, Arch Capital Group Ltd. is actually cheaper at 10. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Arch Capital Group Ltd. wins at 0. 35x versus Goosehead Insurance, Inc's 1. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GSHD or SLQT or HIFS or RYAN or ACGL?
Over the past 5 years, Arch Capital Group Ltd.
(ACGL) delivered a total return of +144. 0%, compared to -96. 1% for SelectQuote, Inc. (SLQT). Over 10 years, the gap is even starker: ACGL returned +324. 0% versus SLQT's -95. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GSHD or SLQT or HIFS or RYAN or ACGL?
By beta (market sensitivity over 5 years), Arch Capital Group Ltd.
(ACGL) is the lower-risk stock at 0. 02β versus SelectQuote, Inc. 's 1. 96β — meaning SLQT is approximately 12729% more volatile than ACGL relative to the S&P 500. On balance sheet safety, Arch Capital Group Ltd. (ACGL) carries a lower debt/equity ratio of 11% versus 3% for Hingham Institution for Savings — giving it more financial flexibility in a downturn.
05Which is growing faster — GSHD or SLQT or HIFS or RYAN or ACGL?
By revenue growth (latest reported year), Ryan Specialty Holdings, Inc.
(RYAN) is pulling ahead at 21. 3% versus 14. 1% for Hingham Institution for Savings (HIFS). On earnings-per-share growth, the picture is similar: SelectQuote, Inc. grew EPS 106. 7% year-over-year, compared to -33. 8% for Ryan Specialty Holdings, Inc.. Over a 3-year CAGR, ACGL leads at 27. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GSHD or SLQT or HIFS or RYAN or ACGL?
Arch Capital Group Ltd.
(ACGL) is the more profitable company, earning 22. 1% net margin versus 2. 1% for Ryan Specialty Holdings, Inc. — meaning it keeps 22. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACGL leads at 25. 0% versus 4. 5% for SLQT. At the gross margin level — before operating expenses — RYAN leads at 90. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GSHD or SLQT or HIFS or RYAN or ACGL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Arch Capital Group Ltd. (ACGL) is the more undervalued stock at a PEG of 0. 35x versus Goosehead Insurance, Inc's 1. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Arch Capital Group Ltd. (ACGL) trades at 10. 1x forward P/E versus 20. 4x for Hingham Institution for Savings — 10. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SLQT: 250. 9% to $4. 00.
08Which pays a better dividend — GSHD or SLQT or HIFS or RYAN or ACGL?
In this comparison, GSHD (9.
1% yield), HIFS (0. 9% yield), RYAN (0. 7% yield) pay a dividend. SLQT, ACGL do not pay a meaningful dividend and should not be held primarily for income.
09Is GSHD or SLQT or HIFS or RYAN or ACGL better for a retirement portfolio?
For long-horizon retirement investors, Ryan Specialty Holdings, Inc.
(RYAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 0. 7% yield). SelectQuote, Inc. (SLQT) carries a higher beta of 1. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RYAN: +20. 0%, SLQT: -95. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GSHD and SLQT and HIFS and RYAN and ACGL?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GSHD is a small-cap high-growth stock; SLQT is a small-cap high-growth stock; HIFS is a small-cap quality compounder stock; RYAN is a small-cap high-growth stock; ACGL is a mid-cap deep-value stock. GSHD, HIFS, RYAN pay a dividend while SLQT, ACGL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.